Kenyan purple tea anthocyanins and coenzyme-Q10 ameliorate post treatment reactive encephalopathy associated with cerebral human African trypanosomiasis in murine model

Parasitology International

Volumn 63, Issue 2, 2014, Pages 417-426

  Rashid, Khalid ^a,b   Wachira, Francis N ^b,c,d   Nyariki, James N ^a   Isaac, Alfred O ^a,c,d  

^a EGERTON UNIVERSITY   (Kenya)

^b TEA RESEARCH FOUNDATION OF KENYA   (Kenya)

^c Association for Strengthening Agricultural Research in Eastern and Central Africa   (Uganda)

^d TECHNICAL UNIVERSITY OF KENYA   (Kenya)

Author keywords

Brain; Coenzyme Q10; Encephalopathy; Human African trypanosomiasis; Melarsoprol; Purple tea anthocyanins

Indexed keywords

ACONITASE 1; ACONITATE HYDRATASE; ANTHOCYANIN; ANTIOXIDANT; DIMINAZENE ACETURATE; GLUTATHIONE; MELARSOPROL; UBIDECARENONE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BODY WEIGHT; BRAIN DISEASE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENLARGED ABDOMEN; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; MICROGLIA; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RELAPSE; SOMNOLENCE; SURVIVAL RATE; TEA; TRYPANOSOMA; TRYPANOSOMA RHODESIENSE; WEAKNESS;

BRAIN; COENZYME-Q(10); ENCEPHALOPATHY; HUMAN AFRICAN TRYPANOSOMIASIS; MELARSOPROL; PURPLE TEA ANTHOCYANINS;

ANIMALS; ANTHOCYANINS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM DISEASES; DIMINAZENE; FEMALE; HEMATOCRIT; HUMANS; MICE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; UBIQUINONE;

EID: 84893378759     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2014.01.001     Document Type: Article

References (52)

1. Remme J.H., Blas E., Chitsulo L., Desjeux P.M., Engers H.D., Kanyok T.P., et al. Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol 2002, 18:421-426.
2. Friedheim E.A.H. Melarsoprol in the treatment of human trypanosomiasis. Am J Trop Med Hyg 1949, 29:173-180.
3. Pepin J., Milrod F. The treatment of human African trypanosomiasis. Adv Parasitol 1994, 33:1-47.
4. Kennedy P.G.E. Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 2006, 36:505-512.
5. Jennings F.W., Gray G.D. Relapsed parasitaemia following chemotherapy of chronic Trypanosoma brucei infections in mice and its relation to cerebral trypanosomes. Contrib Microbiol Immunol 1983, 7:147-154.
6. Kennedy P.G.E. The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of human African trypanosomiasis. J Neuroimmunol 1999, 100:36-41.
7. Adams J.H., Haller L., Boa F.Y., Dago F., Dago A., Konian K. Human African trypanosomiasis (T. b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathol Appl Neurobiol 1986, 12:81-94.
8. Kennedy P.G.E. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004, 113:496-504.
9. Hunter C.A., Jennings F.W., Kennedy P.G.E., Murray M. Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. Lab Invest 1992, 67:635-642.
10. Hunter C.A., Gow J.W., Kennedy P.G.E., Jennings F.W., Murray M. Immunopathology of experimental African sleeping sickness. Detection of cytokine mRNA in the brains of Trypanosoma brucei brucei infected mice. Infect Immun 1991, 59:4636-4640.
11. Hanisch U.K. Microglia as a source and target of cytokine. Glia 2002, 40:140-155.
12. Hunter C.A., Jennings F.W., Kennedy P.G.E., Murray M. The use of azathioprine to ameliorate post-treatment encephalopathy associated with African trypanosomiasis. Neuropathol Appl Neurobiol 1992, 18:619-625.
13. Kennedy P.G.E., Rodgers J., Jennings F.W., Murray M., Leeman S.E., Burke J.M. A Substance P antagonist, RP-67,580 ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci U S A 1997, 94:4167-4170.
14. Pepin J., Milord F., Guern C., Mpia B., Ethier L., Mansina D. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness. Lancet 1989, 1:1246-1250.
15. Rodgers J., Jones A., Gibaud S., Bradley B., McCabe C., Barrett M.P., et al. Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. PLoS Negl Trop Dis 2011, 5:e1308.
16. Crozier A., Jaganath I., Clifford M.N. Phenols, Polyphenols and Tannins 2006, 1-24. Blackwell Publishing, Oxford.
17. Kahkonen M.P., Heinonen M. Antioxidant activity of anthocyanins and their aglycons. J Agric Food Chem 2003, 51:628-633.
18. Youdim K.A., Joseph J.A. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 2001, 30:583-594.
19. Viskelis P., Rubiskiene M., Jasutiene I., Sarkinas A., Daubaras R., Cesoniene L. Anthocyanins, antioxidative and antimicrobial properties of American cranberry (Vaccinium macrocarpon Ait.) and their press cakes. J Food Sci 2009, 74:157-161.
20. Frei B., Kim M.C., Ames B.N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci U S A 1990, 87:4879-4883.
21. Sharma S.K., El Refaey H., Ebadi M. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme-Q10. Brain Res Bull 2006, 70:22-32.
22. Schmelzer C., Lindner I., Rimbach G., Niklowitz P., Menke T., Doring F. Functions of coenzyme-Q10 in inflammation and gene expression. Biofactors 2008, 32:179-183.
23. Kerio L.C., Wachira F.N., Wanyoko J.K., Rotich M.K. Characterization of anthocyanins in Kenyan teas: extraction and identification. Food Chem 2012, 131:31-38.
24. Guisti M.M., Wrolstad R.E. Characterization of red radish anthocyanins. J Food Sci 1996, 61:322-326.
25. Kagira J.M., Thuita J.K., Ngotho J.M., Mwangangi D.M., Ndung'u J.M. Hematology of experimental Trypanosoma brucei rhodesiense infection in vervet monkeys. Afr J Health Sci 2006, 13:59-65.
26. Gichuki C., Brun R. Animal models of CNS (second stage) sleeping sickness. Handbook of Animal Models of Infection 1999, 795-800. AcademicPress. O. Zak, M.A. Sande (Eds.).
27. Herbert W.J., Lumsden W.H.R. A rapid matching method for estimating the host's parasitaemia. Exp Parasitol 1976, 40:427-431.
28. Murray M., Murray P.K., McIntyre W.I.M. An improved parasitological technique for the diagnosis of African trypanosomiasis. Trans R Soc Trop Med Hyg 1977, 71:325-332.
29. Woo P.T.K. The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Trop 1970, 27:384-386.
30. Rahman I., Kode A., Biswas S.K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2007, 1:3159-3165.
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
32. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979, 76:4350-4354.
33. Lau F.C., Bielinski D.F., Joseph J.A. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J Neurosci Res 2007, 85:1010-1017.
34. Hou D., Yanagita T., Uto T., Masuzaki S., Fujii M. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochem Pharmacol 2005, 70:417-425.
35. Tsuda T., Horio F., Osawa T. Cyanidin 3-O-beta-d-glucoside suppresses nitric oxide production during a zymosan treatment in rats. J Nutr Sci Vitaminol 2002, 48:305-310.
36. Fierer J., Salmon J.A., Askonas B.A. African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages. Clin Exp Immunol 1984, 58:548-556.
37. Fuller B., Smith D., Howerton A., Kern D. Anti-inflammatory effects of Co-Q10 and colorless carotenoids. J Cosmet Dermatol 2005, 5:30-38.
38. Flint D.H., Tuminello J.F., Emptage M.H. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 1993, 268:22369-22376.
39. Cavigelli M., Li W.W., Lin A., Su B., Yoshioka K., Karin M. The tumour promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. Eur Mol Biol Org J 1996, 15:6269-6279.
40. He S., Dayton A., Kuppusamy A., Werbovetz K.A., Drew M.E. Induction of oxidative stress in Trypanosoma brucei by the anti-trypanosomal dihydroquinoline OSU-40. Antimicrob Agents Chemother 2012, 56:2428-2434.
41. Ahmed H.H., Shousha W.G., Hussien R.M., Farrag A.R.H. Potential role of some nutraceuticals in the regression of Alzheimer's disease in an experimental animal model. Turk J Med Sci 2011, 41:455-466.
42. Fouad A.A., Al-Sultan A.I., Refaie S.M., Yacoubi M.T. Coenzyme-Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010, 274:49-56.
43. Sohal R.S., Forster M.J. Coenzyme Q, oxidative stress and aging. Mitochondrion 2007, 7:103-111.
44. Abdin A.A., Hamouda H.E. Mechanism of the neuroprotective role of coenzyme-Q10 with or without l-dopa in rotenone-induced parkinsonism. Neuropharmacology 2008, 55:1340-1346.
45. Forsmark-Andree P., Ernster L. Evidence for a protective effect of endogenous ubiquinol against oxidative damage to mitochondrial protein and DNA during lipid peroxidation. Mol Aspects Med 1994, 15:73-81.
46. Kerio L.C., Bend J.R., Wachira F.N., Wanyoko J.K., Rotich M.K. Attenuation of t- Butylhydroperoxide induced oxidative stress in HEK 293 WT cells by tea catechins and anthocyanins. J Toxicol Environ Health 2011, 14:367-375.
47. Vickerman K. Developmental cycles and biology of pathogenic trypanosomes. Br Med Bull 1985, 41:105-114.
48. Ndung'u K., Ngotho M., Kinyua J., Kagira J., Guya S., Ndung'u J., et al. Pathogenicity of bloodstream and cerebrospinal fluid forms of Trypanosoma brucei rhodesiense in Swiss white mice. Afr J Health Sci 2008, 15:34-41.
49. Wolburg H., Mogk S., Acker S., Frey C., Meinert M., Schonfeld C., et al. Late stage infection in sleeping sickness. PLoS One 2012, 7:1371-1378.
50. Pentreath V.W., Owolabi A.O., Doua F. Survival of T. brucei in cerebrospinal fluid. Ann Trop Med Parasitol 1992, 86:29-34.
51. Jenkins G.C., Facer C.A. Hematology of African trypanosomiasis. Immunology and Pathogenesis of Trypanosomiasis 1985, 13-44. CRC Press, Boca Raton, Florida. I. Tizard (Ed.).
52. Rrapo E., Zhu Y., Tian J., Hou H., Smith A., Fernandez F., et al. Green tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice. Am J Transl Res 2009, 1:72-79.